Acute studies on safety index of nonsteroidal anti-inflammatory drugs in rats

Inflammopharmacology

Volumn 9, Issue 3, 2001, Pages 229-240

  Jain, Naveen K ^a   Kulkarni, S K ^a   Singh, Amarjit ^b  

^a PANJAB UNIVERSITY   (India)

^b Panacea Biotec Ltd   (India)

Author keywords

Non steroidal anti inflammatory drugs; Preferential COX 2 inhibitors; Safety index (ulcerogenic dose50 effective anti inflammatory dose50).

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; MELOXICAM; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING; CONTROLLED STUDY; DIGESTIVE SYSTEM PERFORATION; DOSE RESPONSE; DRUG POTENCY; DRUG SAFETY; GASTROINTESTINAL SYMPTOM; HUMAN; INFLAMMATION; NONHUMAN; PAIN; PAW EDEMA; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; STOMACH EPITHELIUM; STOMACH PARIETAL CELL; ULCEROGENESIS;

EID: 0036088801     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1163/156856001760209770     Document Type: Article

References (30)

1. Selective inhibition of human cyclooxygenase-2 by meloxicam
2. Correlation between gastric irritancy and anti-inflammatory activity of non-steroidal anti-inflammatory drugs
3. Anti-inflammatory drugs interacting with Zn(II), Cd(II) and Pt(II) metal ions
4. Indomethacin damage to rat gastric mucosa is markedly dependent on luminal pH
5. Clinical implcations of selective cycloxygenase-2 inhibition
6. Anti-inflammatory, analgesic, antipyretic and related properties of meloxicam, a new non-steroidal anti-inflammatory agent with favourable gastrointestinal tolerance
7. Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs
8. Epidemiology of NSAIDs-related gastrointestinal side effects
9. COX-2 inhibitors
10. Absorption of drugs from the stomach
11. Mechanisms of non-steroidal anti-inflammatory drug-induced gastric damage: Actions of therapeutic agents
12. Analgesic, anti-inflammatory and ulcerogenic activity of a zinc-naproxen complex in mice and rats
13. COX-2 TNF-α and apoptosis: Newer strategies in inflammatory disorders
14. Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibitors
15. Risk of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs
16. Nonsteroidal and anti-inflammatory drug associated ulcer: Epidemiology, causation and treatment
17. Gastroduodenal mucosa and dyspeptic symptoms in arthritis patients during chronic nonsteroidal anti-inflammatory drugs use
18. COX-2 selective NSAIDs: Biology, promises and concerns
19. Epidemiological and financial aspects of the use of nonsteroidal anti-inflammatory analgesics
20. Differential inhibition of cyclooxygenase activity of prostaglandin endoperoxide synthase isozymes in vitro and ex vivo in man
21. Profile and mechanisms of gastrointestinal and other side effects of nonsteroidal anti-inflammatory drugs (NSAIDs)
22. a of nimesulide
23. Effects of nitric oxide-releasing aspirin derivative on gastric functional and ulcerogenic responses in rats: Comparison with plain aspirin
24. Anti-inflammatory drugs and their mechanism of action
25. New insights into the mode of action of anti-inflammatory drugs
26. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years
27. New generation NSAIDs: The benefits without the risks
28. Nonsteroidal drug selectivities for cyclooxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis
29. Carrageenan induced oedema in hind paw of the rat as an assay for anti-inflammatory drugs